Angiogenesis and growth factor expression in a model of transmyocardial revascularization

Annals of Thoracic Surgery

Volumn 66, Issue 1, 1998, Pages 12-18

  Pelletier, Marc P ^a   Giaid, Adel ^a   Sivaraman, Sujith ^a   Dorfman, Julia ^a   Li, Carlos M ^a   Philip, Anie ^a   Chiu, Ray C J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; IMAGE ANALYSIS; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANIMALS; COLORING AGENTS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; FACTOR VIII; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LASER SURGERY; LYMPHOKINES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; NEEDLES; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED LEW; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASCULAR PATENCY;

EID: 0032127411     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00388-9     Document Type: Article

References (25)

1. 1. Mirhoseini M, Shelgikar S, Cayton MM. Transmyocardial laser revascularization: a review. J Clin Laser Med Surg 1993; 11:15-9.
2. 2. Crew JR, Thuener M, Jones R, Ryan C, Chimenti C, Fisher JC. Transmyocardial laser revascularization [Abstract]. J Am Coll Cardiol 1994;23:151A.
3. 3. Mirhoseini M, Cayton MM, Shelgikar S. Transmyocardial laser revascularization [Abstract]. J Am Coll Cardiol 1994;23: 416A.
4. 4. Frazier OH, Cooley DA, Kadipasaoglu KA, et al. Myocardial revascularization with laser: preliminary findings. Circ 1995; 92(Suppl 2):58-65.
5. 5. Whittaker P, Rakusan K, Kloner RA. Transmural channels can protect ischemic tissue: assessment of long-term myocardial response to laser- and needle-made channels. Circulation 1996;93:143-52.
6. 6. Horvath KA, Cohn LH, Cooley DA, et al. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 1997;113:645-54.
7. 7. Mack CA, Magovern CJ, Hahn RT. Channel patency and neovascularization after transmyocardial revascularization using an excimer laser: results and comparisons to nonlased channels. Circulation 1997;96(Suppl 2):65-9.
8. 8. Cooley DA, Frazier OH, Kadipasaoglu KA, Pehlivanoglu S, Shannon RL, Angelini P. Transmyocardial laser revascularization: anatomic evidence of long-term channel patency. Tex Heart Inst J 1994;21:220-4.
9. 9. Zlotnick AY, Ahmad RM, Reul RM, et al. Neovascularization occurs at the site of closed laser channels after transmyocardial laser revascularization. Surg Forum 1996;47:286-7.
10. 10. Burkhoff D, Fisher PE, Apfelbaum M, Kohmoto T, DeRosa CM, Smit CR. Histologic appearance of transmyocardial laser channels after 4 1/2. weeks. Ann Thorac Surg 1996;61: 1532-5.
11. 2 laser. Ann Thorac Surg 1997;63:1275-83.
12. 12. Gassler N, Wintzer H-O, Stube H-M, Wullbrand A, Helmehen U. Transmyocardial laser revascularization: histological features in human nonresponder myocardium. Circulation 1997;95:371-5.
13. 13. Battegay EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995;73:333-46.
14. 14. Iruela-Arispe ML, Sage EH. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-β1. J Cell Biochem 1993;52:414-30.
15. 15. Sakuda H, Nakashima Y, Kuriyama S, Sueishi K. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis: a relationship to transforming growth factor-β1. Am J Pathol 1992;141:1507-16.
16. 16. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PA) procedures. J Histochem Cytochem 1981;29:577-80.
17. 17. Weibel ER. Stereological methods, vol 1. 1st ed. New York: Academic Press, 1979:122.
18. 18. March RJ, Aranki S, Boyce S, et al. Improved event free survival following transmyocardial laser revascularization versus medical management in patients with unreconstructed coronary artery disease. Presented at the annual meeting of The American Association for Thoracic Surgery, Washington, DC, May 4-7, 1997.
19. 19. Davidson JM. Wound repair. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. 2nd ed. New York: Raven Press, 1992:809-19.
20. 20. Cromack DT, Porras-Reyes B, Mustoe TA. Current concepts in wound healing: growth factor and macrophage interaction. J Trauma 1990;30:S129-33.
21. 21. Wahl SM, Hunt DA. Transforming growth factor beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:5788-92.
22. 22. Postlethwaite AI, Keski-Oja J. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 1987;165:251-6.
23. 23. Pepper MS, Mandriota SJ, Vassalli JD, et al. Angiogenesis-regulating cytokines: activities and interactions. Curr Top Microbiol Immunol 1996;213:31-67.
24. 24. Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994;94:623-30.
25. 25. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-3.